Cargando…
Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug
Glioma stem cell (GSC)-targeted therapy is expected to be one of the most innovative approaches to treat patients with glioblastoma (GBM). A number of the drugs that restrain the signaling pathway essential for GSC maintenance have been under clinical trials. Here, we identified fluspirilene, a trad...
Autores principales: | Dong, Yu, Furuta, Takuya, Sabit, Hemragul, Kitabayashi, Tomohiro, Jiapaer, Shabierjiang, Kobayashi, Masahiko, Ino, Yasushi, Todo, Tomoki, Teng, Lei, Hirao, Atsushi, Zhao, Shi-Guang, Nakada, Mitsutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762355/ https://www.ncbi.nlm.nih.gov/pubmed/29340087 http://dx.doi.org/10.18632/oncotarget.22904 |
Ejemplares similares
-
CBMS-12 PENTAMIDINE; TRANSLATIONAL RESEARCH FOR A NEW CHEMOTHERAPY TARGETING ON GLIOMA CELLS AND GLIOMA STEM CELLS USING DRUG REPOSITIONING
por: Tamai, Sho, et al.
Publicado: (2019) -
Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma
por: Kitabayashi, Tomohiro, et al.
Publicado: (2019) -
Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects
por: Tamai, Sho, et al.
Publicado: (2023) -
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018) -
RBPJ contributes to the malignancy of glioblastoma and induction of proneural‐mesenchymal transition via IL‐6‐STAT3 pathway
por: Zhang, Guangtao, et al.
Publicado: (2020)